List of Veeva OpenData Customers
Veeva Systems
4280 Hacienda Drive,
Pleasanton, 94588, CA,
United States
Pleasanton, 94588, CA,
United States
1 925-452-6500
Professional Services
7291
$3.1B
Since 2010, our global team of researchers has been studying Veeva OpenData customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veeva OpenData for Customer Data Platform from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veeva OpenData for Customer Data Platform include: Boehringer Ingelheim, a Germany based Life Sciences organisation with 54500 employees and revenues of $28.94 billion, Alnylam Pharmaceuticals, Inc., a United States based Life Sciences organisation with 2002 employees and revenues of $1.04 billion, Karyopharm Therapeutics, a United States based Life Sciences organisation with 385 employees and revenues of $157.0 million, Verista, a United States based Life Sciences organisation with 650 employees and revenues of $150.0 million, Nektar Therapeutics, a United States based Life Sciences organisation with 216 employees and revenues of $92.0 million and many others.
Contact us if you need a completed and verified list of companies using Veeva OpenData, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veeva OpenData customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Alnylam Pharmaceuticals, Inc. | Life Sciences | 2002 | $1.0B | United States | Veeva Systems | Veeva OpenData | Customer Data Platform | 2015 | n/a |
In 2015, Alnylam Pharmaceuticals, Inc. implemented Veeva OpenData as its Customer Data Platform to establish a centralized reference for physician and account master records across commercial and medical functions. The deployment focused on consolidating Physician Master Data and Account Master Data to serve Medical Affairs and Commercial Systems, and to underpin an internal Patient Services Hub used in specialty pharmacy partner selection and patient services metrics reporting.
Configuration of Veeva OpenData emphasized entity resolution, data harmonization, deduplication, and stewardship workflows typical of a Customer Data Platform, with implementation tailored to support Medical Information, Medical Publication Planning, Grants Management, Promotional and Non-Promotional Material Review, and Aggregate Spend Reporting. The implementation provided a governed master data layer used for downstream reporting and analytics and to supply consistent reference data for quality documentation and regulatory submission processes.
Veeva OpenData was integrated with a broader Veeva ecosystem and enterprise tooling, including Veeva CRM, Veeva Network, Veeva Vault PromoMats, Veeva Vault Quality Docs, Veeva Vault Submissions, Salesforce.com ServiceCloud, Alteryx, and Tableau to enable data propagation, analytics pipelines, and content governance. Operational coverage spanned Medical Affairs and Commercial Systems in Cambridge, MA and supported cross-functional workflows connecting commercial CRM, medical affairs CRM, and patient services operations.
Governance and rollout were driven by a Strategic Technologies lead who defined the technology roadmap, led data privacy planning and implementation, and aligned master data workflows to support the commercial launch of patisiran and associated metrics reporting. The implementation positioned Veeva OpenData as the authoritative source for provider and account identity, with data stewardship and process controls embedded into governance for ongoing maintenance and integration.
|
 |
Boehringer Ingelheim | Life Sciences | 54500 | $28.9B | Germany | Veeva Systems | Veeva OpenData | Customer Data Platform | 2025 | n/a |
In 2025, Boehringer Ingelheim standardized customer data across more than 100 countries by implementing Veeva OpenData as its Customer Data Platform. The initiative extends an existing partnership with Veeva and centers on harmonizing customer reference data to support healthcare professional engagement and to establish a data foundation to scale AI capabilities.
Veeva OpenData was implemented to provide accurate and comprehensive customer reference records, paired with Veeva Network for global master data harmonization and entity resolution. Configuration work focused on creating a unified customer view for field and brand teams, enforcing standardized data models and validation rules, and consolidating the companys data strategy into a single, consolidated solution to simplify data management and reduce fragmentation.
The deployment leverages native integrations between Veeva OpenData and Veeva Network, and it is explicitly connected to Veeva Vault CRM to streamline downstream customer engagement workflows. Operational scope covers global commercial functions, with field and brand teams and the human pharma global customer experience excellence and business steering organization cited as primary business consumers across regions.
Governance changes emphasize global data standardization and cross-team collaboration, with stewardship and harmonization processes to ensure fast access to consistent, high-quality customer data. Consolidation to Veeva OpenData as the Customer Data Platform is described as improving collaboration across teams and enabling coordinated interactions focused on patient outcomes, while also preparing data infrastructure for future AI use cases.
|
 |
Boehringer Ingelheim Veterinary Research Center & Co. | Life Sciences | 13 | $3M | Germany | Veeva Systems | Veeva OpenData | Customer Data Platform | 2025 | n/a |
In 2025, Boehringer Ingelheim Veterinary Research Center & Co. implemented Veeva OpenData as its Customer Data Platform alongside Veeva Network to harmonize customer reference data across its commercial footprint. The deployment is positioned to standardize customer records in support of field, brand, sales, marketing, and medical teams across more than 100 countries, creating a unified customer view for coordinated HCP engagement.
The Veeva OpenData deployment focuses on providing accurate and comprehensive customer reference data, while Veeva Network operates as the master data hub within the Vault CRM Suite to connect sales, marketing, and medical workflows. Veeva OpenData and Veeva Network are described as part of Veeva Data Cloud, which also includes Veeva Link, Veeva Compass, and Veeva CRM Pulse, enabling consolidated master data management, standardized reference records, and a data foundation designed to support scaling AI initiatives.
Architecturally the implementation emphasizes native integrations between OpenData and Vault CRM, with Veeva Network synchronizing cleaned and harmonized customer records into the CRM layer for operational use by commercial and medical teams. The integration pattern described leverages the Veeva ecosystem to streamline the migration path to Veeva Vault CRM by using native OpenData and Network connectivity, reducing the need for bespoke data transformation services.
Governance and rollout are centered on a consolidated data strategy that simplifies data management and enforces standardized record formats and ownership, improving cross-team collaboration and accelerating access to consistent, high-quality customer data. Public statements from the vendor indicate the program is intended to enable coordinated engagement, support migration to Vault CRM, and lay the groundwork for future AI use cases, while maintaining a unified customer view for field and brand users.
|
 |
Karyopharm Therapeutics | Life Sciences | 385 | $157M | United States | Veeva Systems | Veeva OpenData | Customer Data Platform | 2018 | n/a |
In 2018, Karyopharm Therapeutics implemented Veeva OpenData as part of a Customer Data Platform deployment to support the company becoming commercial ready. The Veeva OpenData deployment sat alongside multiple Veeva applications deployed that year, including Veeva CRM, Veeva Network, Approved Email, Veeva Vault PromoMats, and MedComm, with Veeva Nitro adopted as the early data warehouse layer by the IT organization.
The implementation emphasized master reference data management and contact resolution consistent with Customer Data Platform capabilities, using Veeva OpenData to provision standardized HCP and HCO reference records across commercial systems. Configurations targeted synchronization and canonicalization workflows to feed Veeva CRM and downstream analytics, while Veeva Nitro functioned as the enterprise data warehouse for stitched commercial and promotional datasets.
Integration and infrastructure choices were explicit and architected for separation of duties and resilience, with two AWS regions provisioned, one active and one disaster recovery, connected via a Transit Gateway. The cloud footprint included an Elastic Load Balancer to enable a Web Application Firewall, and Amazon Managed Active Directory with a two way trust to create a resource forest that isolated vendor access to ERP resources. Okta was implemented to provide single sign on for cloud applications, Rapid7 was engaged for managed security with InsightIDR and InsightVM, ValueCentric provided managed aggregation of third party data, and SiSense served as the business intelligence platform.
Governance and operating model changes accompanied the technical rollout, including creation of an Enterprise Application team of senior IT application leads and business partners, an IT Strategy Team chaired by IT leadership, adoption of a shift left support model with training and FAQs, a single knowledgebase for internal and external IT teams, and initiation of Objectives and Key Results to improve cross functional initiative collaboration. Veeva OpenData was explicitly positioned within this governed operating model to centralize customer reference data for commercial, medical communication, and promotional use cases.
|
 |
Nektar Therapeutics | Life Sciences | 216 | $92M | United States | Veeva Systems | Veeva OpenData | Customer Data Platform | 2019 | n/a |
In 2019, Nektar Therapeutics implemented Veeva OpenData. The Veeva OpenData deployment served as the Customer Data Platform to provide standardized Healthcare Professional and Organization reference data and search functionality for commercial and medical workflows. The implementation centered on delivering authoritative HCP and HCO master records and search capabilities to support contact enrichment, segmentation, and lookup workflows used by Medical Communications and Medical Science Liaison teams.
Veeva OpenData was integrated with Veeva MedComms Vault and Veeva CRM to enable cross-application lookup and the push of verified HCP and HCO data into MedComms review workflows and the Salesforce based CRM used by Medical Science Liaisons. Program governance was led by internal IT program management, which coordinated project milestones with vendors, managed CapEx and contract negotiations, and provided ongoing application administration and backup SharePoint administration. The operational scope included Medical Communications, regulatory review touchpoints, and MSL field operations, with Veeva OpenData functioning as the authoritative HCP/HCO dataset for downstream Vault and CRM processes, leveraging data normalization and identity resolution to maintain consistent provider records across systems.
|
 |
|
Life Sciences | 280 | $40M | United Kingdom | Veeva Systems | Veeva OpenData | Customer Data Platform | 2019 | n/a |
|
|
|
|
Life Sciences | 150 | $50M | United States | Veeva Systems | Veeva OpenData | Customer Data Platform | 2014 | n/a |
|
|
|
|
Life Sciences | 50 | $10M | United Kingdom | Veeva Systems | Veeva OpenData | Customer Data Platform | 2017 | n/a |
|
|
|
|
Life Sciences | 650 | $150M | United States | Veeva Systems | Veeva OpenData | Customer Data Platform | 2019 | n/a |
|
Showing 1 to 9 of 9 entries
Buyer Intent: Companies Evaluating Veeva OpenData
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Veeva OpenData. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Veeva OpenData for Customer Data Platform include:
- Farmer Environmental Group, a United States based Professional Services organization with 37 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Veeva OpenData Coverage
Veeva OpenData is a Customer Data Platform solution from Veeva Systems.
Companies worldwide use Veeva OpenData, from small firms to large enterprises across 21+ industries.
Organizations such as Boehringer Ingelheim, Alnylam Pharmaceuticals, Inc., Karyopharm Therapeutics, Verista and Nektar Therapeutics are recorded users of
Veeva OpenData for Customer Data Platform.
Companies using Veeva OpenData are most concentrated in Life Sciences, with adoption spanning over 21 industries.
Companies using Veeva OpenData are most concentrated in Germany and United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Veeva OpenData across Americas, EMEA, and APAC.
Companies using Veeva OpenData range from small businesses with 0-100 employees - 22.22%, to mid-sized firms with 101-1,000 employees - 55.56%, large organizations with 1,001-10,000 employees - 11.11%, and global enterprises with 10,000+ employees - 11.11%.
Customers of Veeva OpenData include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Veeva OpenData customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Customer Data Platform.